Financial Statements — TOP
Balance Sheet
(in millions USD)| Metric | Q1
2027 | Q2
2026 | Q2
2025 | Q2
2024 | Q2
2022 |
|---|
| Cash & Equivalents | 10.41 | 14.79 | 12.71 | 24.52 | 23.49 |
| Net Loans & Leases | 81.18 | 8.25 | 2.09 | -- | -- |
| Total Assets | 158.41 | 64.07 | 60.10 | 42.91 | 38.62 |
| Total Liabilities | 121.41 | 29.11 | 20.18 | 3.92 | 4.11 |
| Retained Earnings | 4.46 | 5.94 | 11.26 | 13.63 | 9.10 |
| Total Stockholder Equity | 36.70 | 34.95 | 39.92 | 38.99 | 34.51 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2027 | Q2
2026 | Q2
2025 | Q2
2024 | Q2
2022 |
|---|
| Provision for Credit Losses | 1.71 | 2.59 | -- | -- | -- |
| Pretax Income | -- | 0.19 | (0.45) | 3.59 | 1.84 |
| Tax Provision | (0.27) | -- | -- | (0.08) | (0.04) |
| Net Income | (0.11) | 0.19 | (0.45) | 3.67 | 1.84 |
| Basic EPS | (0.02) | 0.01 | (0.01) | 0.10 | -- |
| Diluted EPS | (0.02) | 0.01 | (0.01) | 0.10 | -- |
Cash Flow Statement
(in millions USD)| Metric | Q1
2027 | Q2
2026 | Q2
2025 | Q2
2024 | Q2
2022 |
|---|
| Operating Cash Flow | 6.03 | 7.29 | (8.16) | 2.48 | (4.72) |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Free Cash Flow* | 6.03 | 7.29 | (8.16) | 2.48 | -- |
| Investing Cash Flow | 7.82 | 1.20 | (8.55) | 4.80 | (0.20) |
| Financing Cash Flow | -- | -- | -- | -- | 22.65 |
* Derived from reported values
